Medical Learning Hub is a product of Tech Care for All, a social impact company that owns and commercializes digital health solutions across Africa and Asia.
Urban poor communities including the homeless, residents of informal settlements, residents at risk of being evicted, Internally Displaced Persons (IDPs), undocumented persons, low-income renters, as well as homeowners are perhaps at greatest risk from both COVID-19 and the response interventions to... it.
more
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...B and/ or hepatitis C are unware of their infection and do not benefit from promotive, preventive and curative services designed to reduce onward transmission. Zambia introduced hepatitis B virus vaccine to the routine Under 5 vaccination schedule in 2005. Preliminary results from the ZAMPHIA indicate that hundreds of infections have been abated in children since then. However, its also clear that we continue to miss key opportunities to prevent transmission, diagnose and treat infections, prevent serious disease, and in many cases cure people. In addition, high risk groups inter alia health care workers still have limited access to the vaccine.
more
Elderly people are at a higher risk of COVID-19 infection due to their decreased immunity and body reserves, as well as multiple associated comorbidities like diabetes, hypertension, chronic kidney disease and chronic obstructive pulmonary disease. Also, course of disease tends to be more severe in ...case of elderlies resulting in higher mortality.
more
Le HCSP a fondé ses recommandations sur les connaissances actuellement disponibles en particulier les publications scientifiques relatives au COVID-19 mais aussi de recommandations relatives à la prise en charge des pneumonies post grippales, et des pneumonies sévères en réanimation.
Cet avi...s du HCSP délivre également des indications sur la prise en charge non spécifique, et de possibles thérapeutiques antivirales, dans l’attente de la mise en place d’essais thérapeutiques académiques afin de progresser dans la connaissance de la maladie. Ces recommandations relatives aux traitements spécifiques seront adaptées en fonction des résultats des essais cliniques lorsqu’ils seront disponibles.
more
Erfahrungen im Umgang mit COVID-19-Erkrankten–Hinweise von Klinikern für Kliniker –
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks al...ong the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.
more
COVID-19 e oxigênio: Os dados da China sugerem que embora a maioria das pessoas com COVID-19 tenham doença leve (40%) ou moderada (40%), cerca de 15% apresentam doença grave que requer oxigenoterapia, e 5% ficam em estado crítico e precisam de tratamento em uma unidade de terapia intensiva. Alé...m disso, a maioria dos pacientes críticos com COVID-19 precisará de ventilação mecânica.2,3 Por esses motivos, as unidades de saúde que tratam da COVID-19 devem estar equipadas com oxímetros de pulso, sistemas de oxigênio em funcionamento, incluindo interfaces de administração de oxigênio de uso único. A oxigenoterapia é recomendada para todos os pacientes graves e críticos com COVID-19, em doses baixas, variando de 1-2 L/min em crianças e começando com 5 L/min em adultos com cânula nasal, fluxos moderados para o uso em máscara de Venturi (6-10 L/min); ou fluxos mais altos (10-15 L/min) com o uso de uma máscara com bolsa reservatório. Além disso, o oxigênio pode ser administrado em fluxos mais altos e em concentrações maiores, usando uma cânula nasal de alto fluxo (CNAF)
more
Technical guidelines for testing for COVID-19 in the clinical laboratories of the National Integrated Health System.
This portal holds a vast collection of guidelines, tools, papers and lessons learnt from across and beyond the ALNAP Membership which are relevant to responding to the current COVID-19 pandemic. The portal is updated on a regular basis and aims to include all resources published on our Member organi...sations’ webpages relevant to the planning, adaptation and delivery of humanitarian activities in response to COVID-19.
more
Mode de Transmission
Symptômes
Prévention
Traitement
Hygiene advice in English, Turkish, Arabic, French and Russian Information in your language
By taking just a few simple measures, you can help protect yourself and others against infectious diseases. Find key hygiene tips here in your language.
Die Infografik "Infektionen vorbeugen: Die 10 wichtig...sten Hygienetipps" der Bundeszentrale für gesundheitliche Aufklärung (BZgA) gibt einen Überblick über einfache persönliche Hygienemaßnahmen, um sich und andere vor ansteckenden Infektionskrankheiten zu schützen. Das Plakat ist in sieben Sprachen verfügbar.
more
As evidências atuais indicam que o vírus causador da doença COVID-19 é transmitido através de gotículas respiratórias ou por contato. A transmissão por contato ocorre quando as mãos contaminadas tocam a mucosa da boca, nariz ou olhos. O vírus também pode ser transferido de uma superfície... para outra através das mãos contaminadas, o que facilita a transmissão por contato indireto. Consequentemente, a higienização das mãos é extremamente importante para evitar a disseminação do vírus causador da doença COVID-19.
more
User Guide.
This Laboratory Assessment Tool (LAT) is specifically designed to assess capacities of existing laboratories which have implemented or aim to implement SARS-CoV-2 testing. It addresses both core capacities of a laboratory and specificities related to SARS-CoV-2 testing. It is a focused... and shorter version from the existing complete laboratory assessment tool that can be found at https://www.who.int/ihr/publications/laboratory_tool/en/
The target audience is any stakeholder performing laboratory assessments such as national health authorities, multilateral agencies, Non-Governmental Organizations (NGOs) and laboratory managers. Assessors can use the tool, and customized if needed, to meet local requirements or assessment context. This tool is an Excel file, which enables automatic calculations of module indicators.
https://www.who.int/publications/i/item/laboratory-assessment-tool-for-laboratories-implementing-covid-19-virus-testing
more
These short videos are very helpful to train health professionals, midwives and mothers
You can download videos in different languages